Nantahala Capital Management LLC has recently announced that it has increased stake in Bioventus Inc. (NASDAQ:BVS) by 63.27%. After grabbing 5.17 million shares, the institutional investor is now in possession of 2.0 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.31% having worth around $5.23 million. Moreover, The Vanguard Group, Inc. increased its share by 5045.0 to have a control over 1.31 million shares. And Millennium Management LLC raised its holdings to 0.99 million shares by acquiring 1.16 million shares or 1.87% of the stake.
Bioventus Inc. (BVS) concluded trading on 05/24/23 at a closing price of $2.56, with 1.23 million shares of worth about $3.14 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 36.17% during that period and on Wednesday the price saw a gain of about 5.35%. Currently the company’s common shares owned by public are about 61.93M shares, out of which, 52.50M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 3 analysts are covering the BVS stock and their offered price forecasts bring an average price target of $2.50. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $3.00 and could fall to a lowest price of $2.00. The stock’s current price level is -2.4% below of average price target set by the analysts, while a dip to estimated low would result in loss of -28.0% for the stock. However, touching the estimated high of $3.00 would mean a gain of 14.67% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 14 times over the past 12 months. They bought 67,766 shares in 9 of the transactions. In 5 selling transactions, insiders dumped 20,713 shares.
Vanguard Total Stock Market ETF, iShares Russell 2000 ETF, and Vanguard Extended Market Index Fu are the top 3 mutual funds which are holding stakes in Bioventus Inc. Vanguard Total Stock Market ETF is currently holding 0.67 million shares of worth totaling $0.68 million. The company recently came buying 0.0 shares which brought its stake up to 1.08% of the company’s outstanding shares. iShares Russell 2000 ETF sold 9280.0 shares, after which its hold over company’s outstanding shares shrunk to 1.01%, leaving 0.63 million shares with the mutual fund that have a worth of about $0.64 million. Vanguard Extended Market Index Fu, after buying 0.48 million shares, have now control over 0.78% of the stake in the company. It holds 0.0 shares of worth $0.49 million.
Bioventus Inc. (NASDAQ: BVS) started trading at $2.41, below -$0.02 from concluding price of the previous day. However, the stock later moved at a day high price of 2.7800, or with a gain of 5.35%. Stock saw a price change of 95.42% in past 5 days and over the past one month there was a price change of 156.00%. Year-to-date (YTD), BVS shares are showing a performance of -1.92% which decreased to -71.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.80 but also hit the highest price of $10.02 during that period. The average intraday trading volume for Bioventus Inc. shares is 1.70 million. The stock is currently trading 104.77% above its 20-day simple moving average (SMA20), while that difference is up 109.31% for SMA50 and it goes to -30.89% lower than SMA200.
Nantahala Capital Management LLC acquired 5.17 million shares of Bioventus Inc. having value of about $5.23 million. Data submitted at the U.S SEC by Nantahala Capital Management LLC revealed that the firm now holds 2.0 million shares in the company valued at close to $5132531.2, or have control over 63.27% stake in the company. Bioventus Inc. (NASDAQ: BVS) currently have 61.93M outstanding shares and institutions hold larger chunk of about 68.50% of that. Holding of mutual funds in the company is about 39.92% while other institutional holders and individual stake holders have control over 7.24% and 23.56% of the stake respectively.
The stock has a current market capitalization of $150.07M. It has posted earnings per share of -$2.58 in the same period. It has Quick Ratio of 0.60 while making debt-to-equity ratio of 1.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BVS, volatility over the week remained 32.08% while standing at 15.46% over the month.
Analysts are in expectations that Bioventus Inc. (BVS) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is -$0.03 and it is $0.18 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.03 which is $0.03 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.1 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -706.70% while it is estimated to increase by 300.00% in next year.
Analysts at 3 brokerage firms have issued recommendations for the Bioventus Inc. (BVS)’s stock and average of those rates the stock at a “Hold” and assign it a score of 3.30. Out of those 3 Wall Street analysts, 0 recommended a “Buy” rating, while 2 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.
Leave a Reply